Simon J Hong
Overview
Explore the profile of Simon J Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jan R, Hong S, Ermann J
Curr Rheumatol Rep
. 2025 Feb;
27(1):17.
PMID: 39891807
Purpose Of Review: There is an unmet need to adequately identify, describe and treat the musculoskeletal manifestations of patients with inflammatory bowel disease (IBD). At the 2024 SPARTAN annual meeting,...
2.
Hong S, Dalal R, Kuhn K, Stahly A, Scott F, Scott F, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39760386
Introduction: Spondyloarthritis (SpA), the most common extraintestinal manifestation of inflammatory bowel disease (IBD), is reported in up to 39% of patients with IBD. Despite this high prevalence, risk factors of...
3.
Ermann J, Hong S, Stahly A, Dalal R, Malik F, Scott F, et al.
Arthritis Care Res (Hoboken)
. 2025 Jan;
PMID: 39748206
Objective: Spondyloarthritis (SpA) is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). The application of screening tools to detect SpA in patients with IBD may lead to earlier...
4.
Malter L, Hong S, Lopatin S, Murphy M, Hudesman D, Kane S, et al.
Inflamm Bowel Dis
. 2024 Jan;
31(3):746-750.
PMID: 38217539
Background: Inflammatory bowel disease (IBD) management has become increasingly complex, and education varies across fellowship programs. IBD 101 was designed to introduce first-year gastroenterology (GI) fellows to IBD care and...
5.
Stone K, Kulekofsky E, Hudesman D, Kozloff S, Remzi F, Axelrad J, et al.
Therap Adv Gastroenterol
. 2023 May;
16:17562848231158231.
PMID: 37124374
Background: The COVID-19 pandemic led to the urgent implementation of telehealth visits in inflammatory bowel disease (IBD) care; however, data assessing feasibility remain limited. Objectives: We looked to determine the...
6.
Hong S, Hudesman D, Scher J
J Rheumatol
. 2023 Feb;
50(7):855-856.
PMID: 36792106
No abstract available.
7.
Hong S, Krugliak Cleveland N, Akiyama S, Zullow S, Yi Y, Shaffer S, et al.
Crohns Colitis 360
. 2023 Feb;
3(1):otab002.
PMID: 36777067
Background: Ustekinumab has been recently approved for the treatment of moderately to severely active ulcerative colitis (UC). The registry trials for ustekinumab in UC demonstrated efficacy and safety, but data...
8.
Hong S, Bhattacharya S, Aboubakr A, Nadkarni D, Lech D, Ungaro R, et al.
Therap Adv Gastroenterol
. 2022 Nov;
15:17562848221132363.
PMID: 36348637
Background: Inflammatory bowel disease (IBD) is not associated with worse coronavirus disease 2019 (COVID-19) outcomes. However, data are lacking regarding the long-term impact of severe acute respiratory syndrome coronavirus 2...
9.
Hong S, Galati J, Katz S
Gastroenterol Clin North Am
. 2022 May;
51(2):425-440.
PMID: 35595423
The incidence and prevalence of inflammatory bowel disease (IBD) is increasing in the elderly population. Compared with patients with onset during younger years, patients with elderly-onset IBD have a distinct...
10.
Haberman R, Um S, Axelrad J, Blank R, Uddin Z, Catron S, et al.
Lancet Rheumatol
. 2022 Apr;
4(6):e384-e387.
PMID: 35403000
No abstract available.